2022
DOI: 10.1016/j.ymeth.2022.07.001
|View full text |Cite
|
Sign up to set email alerts
|

The prognostic value of machine learning techniques versus cox regression model for head and neck cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(16 citation statements)
references
References 29 publications
0
16
0
Order By: Relevance
“…Each patient’s risk score was calculated as previously described ( Peng et al, 2022 ). Furthermore, the risk score of each ACC patient was directly computed using the above formula.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Each patient’s risk score was calculated as previously described ( Peng et al, 2022 ). Furthermore, the risk score of each ACC patient was directly computed using the above formula.…”
Section: Resultsmentioning
confidence: 99%
“…The results of Figures 2C, D determined that the model fit best when the penalty coefficient was 3, and the corresponding three immune genes, TNFAIP3, AURKA, and HELLS, were included in the model (Figure 2E). Each patient's risk score was calculated as previously described (Peng et al, 2022). Furthermore, the risk score of each ACC patient was directly computed using the above formula.…”
Section: Construction and Prognostic Value Of Irssmentioning
confidence: 99%
“…Patients with sinonasal NHL were identified from the Surveillance, Epidemiology, and End Results (SEER) Program (https://seer.cancer.gov/seerstat/), which comprises 18 population‐based cancer registries from the United States, and cancer data were collected between 1975 and 2017 by professionals 20,21 …”
Section: Methodsmentioning
confidence: 99%
“…Patients with sinonasal NHL were identified from the Surveillance, Epidemiology, and End Results (SEER) Program (https://seer.cancer.gov/seerstat/), which comprises 18 population-based cancer registries from the United States, and cancer data were collected between 1975 and 2017 by professionals. 20,21 SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). Institutional Review Board (IRB) approval was waived by the local ethics committee, as SEER data is publicly available and deidentified.…”
Section: Data Sourcementioning
confidence: 99%
See 1 more Smart Citation